Mélanie Lambert

740 total citations
25 papers, 456 citations indexed

About

Mélanie Lambert is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Mélanie Lambert has authored 25 papers receiving a total of 456 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pulmonary and Respiratory Medicine, 7 papers in Molecular Biology and 7 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Mélanie Lambert's work include Pulmonary Hypertension Research and Treatments (14 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (2 papers) and Fuel Cells and Related Materials (2 papers). Mélanie Lambert is often cited by papers focused on Pulmonary Hypertension Research and Treatments (14 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (2 papers) and Fuel Cells and Related Materials (2 papers). Mélanie Lambert collaborates with scholars based in France, United States and United Kingdom. Mélanie Lambert's co-authors include Fabrice Antigny, Marc Humbert, David Montani, Barbara Girerd, Frédéric Perros, Véronique Capuano, Chandran Nagaraj, Angèle Boët, Andrea Olschewski and Jessica Sabourin and has published in prestigious journals such as Circulation, International Journal of Molecular Sciences and Medicine & Science in Sports & Exercise.

In The Last Decade

Mélanie Lambert

20 papers receiving 454 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mélanie Lambert France 12 307 188 178 64 41 25 456
Pedro Mendes‐Ferreira Portugal 12 266 0.9× 145 0.8× 235 1.3× 74 1.2× 35 0.9× 25 464
Qian-min Tao China 7 178 0.6× 135 0.7× 126 0.7× 79 1.2× 34 0.8× 14 360
Mehran Mandegar United States 5 246 0.8× 182 1.0× 129 0.7× 47 0.7× 111 2.7× 7 404
David Ishizawar United States 9 235 0.8× 88 0.5× 92 0.5× 74 1.2× 24 0.6× 20 409
Mohammad Afaque Alam United States 11 119 0.4× 160 0.9× 152 0.9× 137 2.1× 18 0.4× 21 466
Takahiro Hiraide Japan 9 131 0.4× 143 0.8× 188 1.1× 91 1.4× 35 0.9× 30 437
Sadafumi Ono Japan 9 247 0.8× 104 0.6× 69 0.4× 70 1.1× 90 2.2× 22 434
Natalie R. Bauer United States 5 363 1.2× 211 1.1× 145 0.8× 50 0.8× 251 6.1× 7 537
Keita Okayama Japan 9 62 0.2× 164 0.9× 119 0.7× 108 1.7× 25 0.6× 20 384
Ruo‐Min Di China 14 102 0.3× 269 1.4× 153 0.9× 40 0.6× 22 0.5× 22 444

Countries citing papers authored by Mélanie Lambert

Since Specialization
Citations

This map shows the geographic impact of Mélanie Lambert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mélanie Lambert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mélanie Lambert more than expected).

Fields of papers citing papers by Mélanie Lambert

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mélanie Lambert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mélanie Lambert. The network helps show where Mélanie Lambert may publish in the future.

Co-authorship network of co-authors of Mélanie Lambert

This figure shows the co-authorship network connecting the top 25 collaborators of Mélanie Lambert. A scholar is included among the top collaborators of Mélanie Lambert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mélanie Lambert. Mélanie Lambert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lambert, Mélanie, et al.. (2025). The senolytic ABT-263 improves cognitive functions in middle-aged male, but not female, atherosclerotic LDLr−/−;hApoB100+/+ mice. GeroScience. 47(3). 4577–4600. 8 indexed citations
2.
Lambert, Mélanie, Gaël Cagnone, Pauline Mury, et al.. (2025). Targeting angiopoietin like-2 positive senescent cells improves cognitive impairment in adult male but not female atherosclerotic LDLr−/−;hApoB100+/+ mice. GeroScience. 47(6). 6999–7022. 1 indexed citations
3.
Lambert, Mélanie, Samy Jambon, Mohamed Amine Bouhlel, et al.. (2024). Induction of AML cell differentiation using HOXA9/DNA binding inhibitors as a potential therapeutic option for HOXA9‐dependent AML. HemaSphere. 8(5). e77–e77. 5 indexed citations
4.
Lambert, Mélanie, Antoine Beurnier, David Montani, et al.. (2023). KCNK3 channel is important for the ventilatory response to hypoxia in rats. Respiratory Physiology & Neurobiology. 318. 104164–104164.
5.
Capuano, Véronique, Mary Dutheil, Angèle Boët, et al.. (2022). SUR1 As a New Therapeutic Target for Pulmonary Arterial Hypertension. American Journal of Respiratory Cell and Molecular Biology. 66(5). 539–554. 17 indexed citations
6.
Hautbergue, Thaïs, Fabrice Antigny, Angèle Boët, et al.. (2021). Right Ventricle Remodeling Metabolic Signature in Experimental Pulmonary Hypertension Models of Chronic Hypoxia and Monocrotaline Exposure. Cells. 10(6). 1559–1559. 18 indexed citations
7.
Lambert, Mélanie, Pedro Mendes‐Ferreira, Maria‐Rosa Ghigna, et al.. (2021). Kcnk3 dysfunction exaggerates the development of pulmonary hypertension induced by left ventricular pressure overload. Cardiovascular Research. 117(12). 2474–2488. 24 indexed citations
8.
Amsallem, Myriam, Andrew J. Sweatt, Jennifer Arthur Ataam, et al.. (2020). Targeted proteomics of right heart adaptation to pulmonary arterial hypertension. European Respiratory Journal. 57(4). 2002428–2002428. 22 indexed citations
9.
Boët, Angèle, Mélanie Lambert, Wendy K. Chung, et al.. (2020). SUR1/Kir6.2 potassium channel a new actor involved in pulmonary arterial hypertension. Archives of Cardiovascular Diseases Supplements. 12(2-4). 214–214. 2 indexed citations
10.
Courboulin, Audrey, Maria‐Rosa Ghigna, Mélanie Lambert, et al.. (2020). In vivo miR-138-5p inhibition alleviates monocrotaline-induced pulmonary hypertension and normalizes pulmonary KCNK3 and SLC45A3 expression. Respiratory Research. 21(1). 186–186. 25 indexed citations
11.
Dumont, Florent, Mélanie Lambert, Thierry Balliau, et al.. (2020). Proteomic Analysis of KCNK3 Loss of Expression Identified Dysregulated Pathways in Pulmonary Vascular Cells. International Journal of Molecular Sciences. 21(19). 7400–7400. 17 indexed citations
12.
Lambert, Mélanie, Angèle Boët, David Montani, et al.. (2020). SUR1/Kir6.2 potassium channel a new actor involved in pulmonary arterial hypertension. 3561–3561. 1 indexed citations
13.
Piquereau, Jérôme, Angèle Boët, Christine Péchoux, et al.. (2019). The BET Bromodomain Inhibitor I-BET-151 Induces Structural and Functional Alterations of the Heart Mitochondria in Healthy Male Mice and Rats. International Journal of Molecular Sciences. 20(7). 1527–1527. 17 indexed citations
14.
Hautefort, Aurélie, Pedro Mendes‐Ferreira, Jessica Sabourin, et al.. (2019). Bmpr2 Mutant Rats Develop Pulmonary and Cardiac Characteristics of Pulmonary Arterial Hypertension. Circulation. 139(7). 932–948. 85 indexed citations
15.
Lambert, Mélanie, Véronique Capuano, Andrea Olschewski, et al.. (2018). Ion Channels in Pulmonary Hypertension: A Therapeutic Interest?. International Journal of Molecular Sciences. 19(10). 3162–3162. 57 indexed citations
16.
Olschewski, Andrea, Emma L. Veale, Bence Nagy, et al.. (2017). TASK-1 (KCNK3) channels in the lung: from cell biology to clinical implications. European Respiratory Journal. 50(5). 1700754–1700754. 57 indexed citations
17.
Nossent, Esther J., Fabrice Antigny, David Montani, et al.. (2017). Pulmonary vascular remodeling patterns and expression of general control nonderepressible 2 (GCN2) in pulmonary veno-occlusive disease. The Journal of Heart and Lung Transplantation. 37(5). 647–655. 44 indexed citations
18.
Wibaut, B., Nathalie Trillot, Philippe Deruelle, et al.. (2011). P.4 Preeclampsia as a risk factor for postnatal pulmonary embolism. Thrombosis Research. 127. S130–S130.
19.
Lambert, Mélanie, et al.. (1978). The binding of phenylbutazone to bovine and horse serum albumin. Irish Journal of Medical Science (1971 -). 147(1). 193–196. 2 indexed citations
20.
Lambert, Mélanie, et al.. (1977). The effect of aspirin on the protein binding of ascorbic acid [proceedings].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 60(2). 300P–300P. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pedro Mendes‐Ferreira Breakdown of academic impact, for papers by Qian-min Tao Breakdown of academic impact, for papers by Mehran Mandegar Breakdown of academic impact, for papers by David Ishizawar Breakdown of academic impact, for papers by Mohammad Afaque Alam Breakdown of academic impact, for papers by Takahiro Hiraide Breakdown of academic impact, for papers by Sadafumi Ono Breakdown of academic impact, for papers by Natalie R. Bauer Breakdown of academic impact, for papers by Keita Okayama Breakdown of academic impact, for papers by Ruo‐Min Di
Rankless by CCL
2026